J. Van Cutsem

5.5k total citations
117 papers, 4.3k citations indexed

About

J. Van Cutsem is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, J. Van Cutsem has authored 117 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 61 papers in Epidemiology and 18 papers in Small Animals. Recurrent topics in J. Van Cutsem's work include Antifungal resistance and susceptibility (64 papers), Nail Diseases and Treatments (54 papers) and Fungal Infections and Studies (27 papers). J. Van Cutsem is often cited by papers focused on Antifungal resistance and susceptibility (64 papers), Nail Diseases and Treatments (54 papers) and Fungal Infections and Studies (27 papers). J. Van Cutsem collaborates with scholars based in Belgium, United States and United Kingdom. J. Van Cutsem's co-authors include Paul A. J. Janssen, F. Van Gerven, Jan Heeres, L. J. J. Backx, Μ. Borgers, Johan R. Boelaert, G. Cauwenbergh, D. Thienpont, Erik F. Godefroi and Yves‐Jacques Schneider and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

J. Van Cutsem

114 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Van Cutsem Belgium 36 2.3k 2.2k 582 512 501 117 4.3k
J N Galgiani United States 36 2.9k 1.3× 3.3k 1.5× 383 0.7× 632 1.2× 162 0.3× 71 4.5k
Annemarie Polak Switzerland 29 1.8k 0.8× 1.9k 0.9× 318 0.5× 500 1.0× 221 0.4× 91 3.0k
Smith Shadomy United States 30 1.9k 0.9× 2.0k 0.9× 292 0.5× 435 0.8× 135 0.3× 108 3.2k
E. G. V. Evans United Kingdom 33 2.2k 1.0× 1.2k 0.6× 192 0.3× 1.1k 2.2× 161 0.3× 97 3.4k
H. Vanden Bossche Belgium 39 1.6k 0.7× 2.0k 1.0× 219 0.4× 301 0.6× 473 0.9× 65 4.2k
Erja Chryssanthou Sweden 30 1.6k 0.7× 1.7k 0.8× 224 0.4× 479 0.9× 198 0.4× 71 2.8k
Robert A. Fromtling United States 25 1.4k 0.6× 1.4k 0.6× 132 0.2× 401 0.8× 414 0.8× 72 2.8k
Aristea Velegraki Greece 38 2.8k 1.2× 2.2k 1.0× 216 0.4× 1.2k 2.3× 154 0.3× 131 5.0k
Hideyo Yamaguchi Japan 44 3.5k 1.5× 3.1k 1.4× 281 0.5× 1.5k 2.9× 350 0.7× 299 8.1k
Jean‐Philippe Bouchara France 44 2.6k 1.1× 2.9k 1.4× 338 0.6× 1.3k 2.5× 373 0.7× 193 5.8k

Countries citing papers authored by J. Van Cutsem

Since Specialization
Citations

This map shows the geographic impact of J. Van Cutsem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Van Cutsem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Van Cutsem more than expected).

Fields of papers citing papers by J. Van Cutsem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Van Cutsem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Van Cutsem. The network helps show where J. Van Cutsem may publish in the future.

Co-authorship network of co-authors of J. Van Cutsem

This figure shows the co-authorship network connecting the top 25 collaborators of J. Van Cutsem. A scholar is included among the top collaborators of J. Van Cutsem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Van Cutsem. J. Van Cutsem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cutsem, J. Van. (2015). Itraconazole and Therapy of Fungal Infections. Current problems in dermatology. 24. 194–202.
2.
André, Josette, et al.. (1995). Onychomycosis caused by Microsporum canis: Treatment with itraconazole. Journal of the American Academy of Dermatology. 32(6). 1052–1053. 12 indexed citations
3.
Arrese, J.E., Philippe Delvenne, J. Van Cutsem, C Piérard-Franchimont, & Gérald Pierard. (1994). Experimental aspergillosis in guinea pigs: influence of itraconazole on fungaemia and invasive fungal growth. Mycoses. 37(3-4). 117–122. 13 indexed citations
4.
Cutsem, J. Van, Hiroshi Kurata, Hirofumi Matsuoka, et al.. (1994). Antifungal drug susceptibility testing. Medical Mycology. 32(s1). 267–276. 10 indexed citations
5.
Borgers, Μ., Benoit Xhonneux, & J. Van Cutsem. (1993). Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis. Mycoses. 36(3-4). 105–115. 18 indexed citations
6.
Boelaert, Johan R., J. Van Cutsem, Brigitte Cantinieaux, et al.. (1993). Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.. Journal of Clinical Investigation. 91(5). 1979–1986. 241 indexed citations
7.
Walsh, Thomas J., J. Van Cutsem, Annemarie Polak, & John R. Graybill. (1992). Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts. Medical Mycology. 30(s1). 225–240. 17 indexed citations
8.
Cutsem, J. Van. (1992). In vitro Antifungal Spectrum of Itraconazole and Treatment of Systemic Mycoses with Old and New Antimycotic Agents. Chemotherapy. 38(1). 3–11. 21 indexed citations
9.
Willemsen, Marcella, Piet De Doncker, Robert Woestenborghs, et al.. (1992). Posttreatment itraconazole levels in the nail. Journal of the American Academy of Dermatology. 26(5). 731–735. 136 indexed citations
10.
Cutsem, J. Van. (1991). The in vitro activity of terconazole against yeasts: Its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. American Journal of Obstetrics and Gynecology. 165(4). 1200–1206. 8 indexed citations
11.
Pierard, Gérald, et al.. (1991). Kefoconazofe 2% Emulsion in the Treatment of Seborrheic Dermatitis. International Journal of Dermatology. 30(11). 806–809. 26 indexed citations
12.
Poulain, Daniel, D. W. R. Mackenzie, & J. Van Cutsem. (1991). Monoclonal antibody‐gold silver staining dot assay for the detection of antigenaemia in candidosis. Mycoses. 34(5-6). 221–226. 6 indexed citations
13.
Poulain, Daniel, Marc Deveaux, Jean‐Charles Cailliez, et al.. (1991). Imaging of systemic Candida albicans infections with a radioiodinated monoclonal antibody: Experimental study in the guinea pig. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(7). 677–686. 8 indexed citations
14.
15.
Roseeuw, Diane, et al.. (1990). Itraconazole in the treatment of superficial mycoses-a double-blind study vs. placebo. Clinical and Experimental Dermatology. 15(2). 101–104. 26 indexed citations
16.
Cutsem, J. Van. (1989). Animal Models for Dermatomycotic Infections. PubMed. 3. 1–35. 22 indexed citations
17.
Cutsem, J. Van & Johan R. Boelaert. (1989). Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney International. 36(6). 1061–1068. 79 indexed citations
18.
Cauwenbergh, G. & J. Van Cutsem. (1988). Role of Animal and Human Pharmacology in Antifungal Drug Design. Annals of the New York Academy of Sciences. 544(1). 264–269. 9 indexed citations
19.
Cutsem, J. Van, et al.. (1985). Primary Cutaneous Cryptococcosis. Dermatology. 171(5). 357–361. 25 indexed citations
20.
Cutsem, J. Van, et al.. (1971). Clinical evaluation of miconazole nitrate in the treatment of vaginal candidiasis. Arzneimittelforschung. 21(2). 256–257. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J N Galgiani Breakdown of academic impact, for papers by Annemarie Polak Breakdown of academic impact, for papers by Smith Shadomy Breakdown of academic impact, for papers by E. G. V. Evans Breakdown of academic impact, for papers by H. Vanden Bossche Breakdown of academic impact, for papers by Erja Chryssanthou Breakdown of academic impact, for papers by Robert A. Fromtling Breakdown of academic impact, for papers by Aristea Velegraki Breakdown of academic impact, for papers by Hideyo Yamaguchi Breakdown of academic impact, for papers by Jean‐Philippe Bouchara
Rankless by CCL
2026